{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:10:15Z","timestamp":1778202615428,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.urolonc.2026.111093","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:44:44Z","timestamp":1775310284000},"page":"128-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Laboratory paraneoplastic syndrome resolution is associated with reduced recurrence and improved survival in non-metastatic renal cell carcinoma"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3205-3944","authenticated-orcid":false,"given":"Reza","family":"Lahiji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke L.","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Mumford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan J.","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dattatraya","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sriram","family":"Ambadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baris","family":"Esen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Luke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Storino Ramacciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Goodstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest A.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Braunschweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Nabavizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram N.","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Grajales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreyas S.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Hajiha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Ogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7251-142X","authenticated-orcid":false,"given":"Viraj A.","family":"Master","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.urolonc.2026.111093_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2023.06.015","article-title":"Incidence and clinical relevance of paraneoplastic syndromes in patients with renal cell carcinoma","volume":"41","author":"Moldovan","year":"2023","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.111093_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2024.102207","article-title":"Paraneoplastic syndrome prevalence and survival in racially-diverse cohort with renal cell carcinoma","volume":"22","author":"Nicaise","year":"2024","journal-title":"Clin Genitourin Cancer"},{"issue":"21","key":"10.1016\/j.urolonc.2026.111093_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16213678","article-title":"Paraneoplastic resolution holds prognostic utility in patients with metastatic renal cell carcinoma","volume":"16","author":"Palmateer","year":"2024","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.urolonc.2026.111093_bib0004","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00345-018-2215-9","article-title":"Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma","volume":"36","author":"Hegemann","year":"2018","journal-title":"World J Urol"},{"issue":"Supplement 5","key":"10.1016\/j.urolonc.2026.111093_bib0005","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000002547.07","article-title":"Pd15-07 renal cell carcinoma paraneoplastic syndrome score: construction and validation","volume":"207","author":"Soliman","year":"2022","journal-title":"J Urol"},{"issue":"102457","key":"10.1016\/j.urolonc.2026.111093_bib0006","article-title":"Impact of hemoglobin A1c on the obesity paradox and survival in patients with non-metastatic renal cell carcinoma","author":"Abdollahzadeh","year":"2025","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111093_bib0007","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jso.20173","article-title":"Disseminated colon cancer with severe peripheral blood eosinophilia and elevated serum levels of interleukine-2, interleukine-3, interleukine-5, and GM-CSF","volume":"89","author":"Anagnostopoulos","year":"2005","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111093_bib0008","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jtcvs.2019.11.052","article-title":"A systematic review of paraneoplastic syndromes associated with thymoma: treatment modalities, recurrence, and outcomes in resected cases","volume":"160","author":"Zhao","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.urolonc.2026.111093_bib0009","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4065\/mcp.2010.0099","article-title":"Paraneoplastic syndromes: an approach to diagnosis and treatment","volume":"85","author":"Pelosof","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.urolonc.2026.111093_bib0010","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4103\/njcp.njcp_35_19","article-title":"Paraneoplastic syndromes and oncological outcomes in renal cancer","volume":"22","author":"Ikuerowo","year":"2019","journal-title":"Niger J Clin Pract"},{"issue":"8","key":"10.1016\/j.urolonc.2026.111093_bib0011","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.urolonc.2025.03.022","article-title":"Paraneoplastic and symptomatic score (PRIMAL) for prediction of overall and cancer-specific survival after surgery in patients with renal cell carcinoma","volume":"43","author":"Musso","year":"2025","journal-title":"Urol Oncol"},{"issue":"10","key":"10.1016\/j.urolonc.2026.111093_bib0012","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00345-016-1793-7","article-title":"Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy","volume":"34","author":"Moreira","year":"2016","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.111093_bib0013","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2484\/rcr.v2i3.72","article-title":"Renal cell carcinoma with paraneoplastic manifestations: imaging with CT and F-18 FDG PET\/CT","volume":"2","author":"Nguyen","year":"2007","journal-title":"Radiol Case Rep"},{"issue":"3","key":"10.1016\/j.urolonc.2026.111093_bib0014","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1097-0215(19970729)72:3<424::AID-IJC9>3.0.CO;2-R","article-title":"Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma","volume":"72","author":"Blay","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2026.111093_bib0015","series-title":"Renal cell carcinoma","first-page":"135","article-title":"Paraneoplastic syndromes in renal cell carcinoma","author":"Aldaabil","year":"2000"},{"issue":"2","key":"10.1016\/j.urolonc.2026.111093_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/rco2.70014","article-title":"Sarcopenia thresholds derived from healthy adult populations predict survival in patients with cancer","volume":"8","author":"Lahiji","year":"2025","journal-title":"JCSM Commun"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111093_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195042","article-title":"Optimal cut-off for neutrophil-to-lymphocyte ratio: fact or fantasy? A prospective cohort study in metastatic cancer patients","volume":"13","author":"Vano","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111093_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11040536","article-title":"Rising serum uric acid level is negatively associated with survival in renal cell carcinoma","volume":"11","author":"Yim","year":"2019","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.urolonc.2026.111093_bib0019","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/bjc.2012.565","article-title":"Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma","volume":"108","author":"Choi","year":"2013","journal-title":"Br J Cancer"},{"issue":"13","key":"10.1016\/j.urolonc.2026.111093_bib0020","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.3390\/jcm13133640","article-title":"The cellular stress and cutaneous manifestations in renal cell carcinomas-a narrative review","volume":"13","author":"Ene","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111093_bib0021","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000458435","article-title":"Paraneoplastic peripheral nervous system manifestations of renal cell carcinoma: a case report and review of the literature","volume":"9","author":"Yang","year":"2017","journal-title":"Case Rep Neurol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926001043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926001043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:29:56Z","timestamp":1778200196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926001043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1078143926001043"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.111093","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laboratory paraneoplastic syndrome resolution is associated with reduced recurrence and improved survival in non-metastatic renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.111093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}